The average price target for Medpace Holdings is $160.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $175.00 ,the lowest forecast is $145.00. The average price target represents 16.58% Increase from the current price of $137.24.

What do analysts say about Medpace Holdings?

Medpace Holdings’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.

When is Medpace Holdings’s upcoming earnings report date?

Medpace Holdings’s upcoming earnings report date is Aug 01, 2022 which is in 76 days.

How were Medpace Holdings’s earnings last quarter?

Medpace Holdings released its earnings results on Apr 25, 2022. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.43.

Is Medpace Holdings overvalued?

According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.

Does Medpace Holdings pay dividends?

Medpace Holdings does not currently pay dividends.

What is Medpace Holdings’s EPS estimate?

Medpace Holdings’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medpace Holdings have?

Medpace Holdings has 33,650,000 shares outstanding.

What happened to Medpace Holdings’s price movement after its last earnings report?

Medpace Holdings reported an EPS of $1.69 in its last earnings report, beating expectations of $1.26. Following the earnings report the stock price went down -10.405%.

Which hedge fund is a major shareholder of Medpace Holdings?

Among the largest hedge funds holding Medpace Holdings’s share is Echo Street Capital Management LLC. It holds Medpace Holdings’s shares valued at 114M.

---

Medpace Holdings Stock Analysis

Smart Score

Outperform

Technicals

SMA

Negative

20 days / 200 days

Momentum

-14.98%

12-Months-Change

Fundamentals

Return on Equity

27.26%

Trailing 12-Months

Asset Growth

-7.37%

Trailing 12-Months

The Medpace Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Medpace Holdings

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

---

Similar Stocks

SYNH

Syneos Health

―

IQV

IQVIA Holdings

―

VYNT

Vyant Bio

―

ICLR